$3.08 Billion is the total value of Alphabet Inc.'s 70 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 6.9% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
DXCM | Buy | Dexcom Inc | $537,484,000 | +42.2% | 1,050,595 | +49.2% | 17.44% | +91.0% |
PATH | UiPath Inccl a | $303,742,000 | -49.9% | 14,068,674 | 0.0% | 9.86% | -32.7% | |
IonQ Inc | $279,534,000 | -23.6% | 21,907,038 | 0.0% | 9.07% | +2.7% | ||
VERV | Verve Therapeutics Inc | $250,427,000 | -38.1% | 10,974,011 | 0.0% | 8.12% | -16.8% | |
OSCR | Oscar Health Inccl a | $239,706,000 | +27.0% | 24,042,864 | 0.0% | 7.78% | +70.7% | |
LYFT | Lyft Inc | $235,705,000 | -10.1% | 6,138,154 | 0.0% | 7.65% | +20.8% | |
EQRX Inc | $196,393,000 | -39.4% | 47,552,687 | 0.0% | 6.37% | -18.6% | ||
Planet Labs PBC | $162,269,000 | -17.4% | 31,942,641 | 0.0% | 5.26% | +11.0% | ||
SNOW | New | Snowflake Inccl a | $122,723,000 | – | 535,604 | +100.0% | 3.98% | – |
RCUS | Arcus Biosciences Inc | $80,902,000 | -22.0% | 2,563,441 | 0.0% | 2.62% | +4.8% | |
Freshworks Inc | $72,318,000 | -31.8% | 4,035,595 | 0.0% | 2.35% | -8.3% | ||
Robinhood Mkts Inc | $66,585,000 | -23.9% | 4,928,535 | 0.0% | 2.16% | +2.2% | ||
DM | Desktop Metal Inc | $52,371,000 | -4.2% | 11,048,730 | 0.0% | 1.70% | +28.6% | |
Buy | Benson Hill Inc | $49,588,000 | -53.9% | 15,352,271 | +4.1% | 1.61% | -38.0% | |
RLAY | Buy | Relay Therapeutics Inc | $46,953,000 | -2.3% | 1,568,753 | +0.3% | 1.52% | +31.3% |
Sell | Toast Inccl a | $31,132,000 | -90.6% | 1,432,660 | -84.9% | 1.01% | -87.3% | |
LYEL | Lyell Immunopharma Inc | $29,619,000 | -34.8% | 5,865,125 | 0.0% | 0.96% | -12.3% | |
Adagio Therapeutics Inc | $25,904,000 | -37.2% | 5,680,785 | 0.0% | 0.84% | -15.7% | ||
ME | 23andMe Holding Co | $25,802,000 | -42.5% | 6,736,785 | 0.0% | 0.84% | -22.7% | |
SANA | Sana Biotechnology Inc | $23,231,000 | -46.6% | 2,812,500 | 0.0% | 0.75% | -28.3% | |
GLUE | Monte Rosa Therapeutics Inc | $20,525,000 | -31.3% | 1,464,015 | 0.0% | 0.67% | -7.8% | |
ILMN | Illumina Inc | $18,682,000 | -8.2% | 53,470 | 0.0% | 0.61% | +23.4% | |
BEAM | Beam Therapeutics Inc | $18,428,000 | -28.1% | 321,604 | 0.0% | 0.60% | -3.4% | |
Science 37 Holdings Inc | $17,340,000 | -57.1% | 3,241,075 | 0.0% | 0.56% | -42.3% | ||
Enjoy Technology Inc | $16,512,000 | -17.8% | 4,345,340 | 0.0% | 0.54% | +10.5% | ||
Duolingo Inc. | $13,738,000 | -10.4% | 144,444 | 0.0% | 0.45% | +20.5% | ||
RAPT | Sell | RAPT Therapeutics Inc | $11,881,000 | -48.5% | 540,270 | -13.9% | 0.38% | -30.9% |
Tenaya Therapeutics Inc | $10,787,000 | -37.8% | 915,705 | 0.0% | 0.35% | -16.5% | ||
KRON | Kronos Bio Inc | $10,398,000 | -46.8% | 1,438,232 | 0.0% | 0.34% | -28.6% | |
MGTA | Magenta Therapeutics Inc | $9,684,000 | -34.5% | 3,339,138 | 0.0% | 0.31% | -12.0% | |
New | Rani Therapeutics Hldgs Inc | $9,645,000 | – | 714,471 | +100.0% | 0.31% | – | |
IDYA | Ideaya Biosciences Inc | $8,428,000 | -52.7% | 753,187 | 0.0% | 0.27% | -36.5% | |
VACC | Sell | Vaccitech PLCads | $7,871,000 | -58.4% | 1,513,644 | -11.2% | 0.26% | -44.2% |
SPRO | Spero Therapeutics Inc | $7,743,000 | -45.7% | 889,979 | 0.0% | 0.25% | -27.0% | |
FHTX | Foghorn Therapeutics Inc | $7,629,000 | -33.4% | 500,901 | 0.0% | 0.25% | -10.5% | |
VERA | Sell | Vera Therapeutics Inccl a | $7,084,000 | -62.9% | 301,580 | -57.7% | 0.23% | -50.0% |
NEWR | New Relic Inc | $6,095,000 | -39.2% | 91,132 | 0.0% | 0.20% | -18.2% | |
FULC | Fulcrum Therapeutics Inc | $6,041,000 | +33.7% | 255,452 | 0.0% | 0.20% | +79.8% | |
DBTX | Decibel Therapeutics Inc | $4,974,000 | -34.6% | 1,636,258 | 0.0% | 0.16% | -12.5% | |
TSHA | Taysha Gene Therapies Inc | $4,179,000 | -44.0% | 640,882 | 0.0% | 0.14% | -24.4% | |
OMIC | Singular Genomics Systems Inc | $3,701,000 | -45.4% | 586,584 | 0.0% | 0.12% | -26.8% | |
EVLO | Evelo Biosciences Inc | $3,595,000 | -44.2% | 1,060,495 | 0.0% | 0.12% | -24.5% | |
Amplitude Inc | $3,492,000 | -65.2% | 189,447 | 0.0% | 0.11% | -53.3% | ||
Hyperfine Inc | $3,181,000 | -51.2% | 898,720 | 0.0% | 0.10% | -34.4% | ||
Tscan Therapeutics Inc | $3,016,000 | -37.8% | 1,077,080 | 0.0% | 0.10% | -16.2% | ||
AUTL | Autolus Therapeutics PLCspon adr | $2,912,000 | -19.6% | 698,262 | 0.0% | 0.09% | +6.8% | |
ALEC | Alector Inc | $2,506,000 | -31.0% | 175,866 | 0.0% | 0.08% | -8.0% | |
NVTA | Invitae Corp | $1,723,000 | -47.8% | 215,965 | 0.0% | 0.06% | -30.0% | |
EXAS | Exact Sciences Corp | $1,622,000 | -10.2% | 23,205 | 0.0% | 0.05% | +20.5% | |
OPRT | Oportun Finl Corp | $1,361,000 | -29.1% | 94,788 | 0.0% | 0.04% | -4.3% | |
CRTX | Cortexyme Inc | $1,169,000 | -51.0% | 189,122 | 0.0% | 0.04% | -34.5% | |
S | Sell | Sentinelone Inccl a | $822,000 | -88.2% | 21,231 | -84.7% | 0.03% | -84.0% |
TWLO | Sell | Twilio Inccl a | $611,000 | -38.5% | 3,710 | -1.7% | 0.02% | -16.7% |
Nextdoor Holdings Inc | $583,000 | -24.1% | 97,391 | 0.0% | 0.02% | 0.0% | ||
SQZ | SQZ Biotechnologies Co | $500,000 | -46.1% | 103,929 | 0.0% | 0.02% | -27.3% | |
WeWork Inccl a | $434,000 | -20.7% | 63,645 | 0.0% | 0.01% | +7.7% | ||
CMPX | Compass Therapeutics Inc | $264,000 | -56.8% | 192,794 | 0.0% | 0.01% | -40.0% | |
SPGI | S&P Global Inc | $243,000 | -12.9% | 592 | 0.0% | 0.01% | +14.3% | |
New | Cue Health Inc | $174,000 | – | 27,000 | +100.0% | 0.01% | – | |
RGEN | Repligen Corp | $72,000 | -28.7% | 383 | 0.0% | 0.00% | 0.0% | |
UBER | Exit | Uber Technologies Inc | $0 | – | -49,466 | -100.0% | -0.05% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
DEXCOM INC | 20 | Q3 2023 | 17.4% |
Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
ALECTOR INC | 19 | Q3 2023 | 1.1% |
Lyft Inc | 18 | Q2 2023 | 51.9% |
QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
144 | 2024-03-28 |
144 | 2024-03-27 |
4 | 2024-03-26 |
4 | 2024-03-26 |
4 | 2024-03-26 |
4 | 2024-03-26 |
4 | 2024-03-26 |
4 | 2024-03-26 |
144 | 2024-03-20 |
144 | 2024-03-20 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.